Pharma Co. Overstated Unpatented Drug's Value, Suit Says
By Sydney Price · January 8, 2024, 6:06 PM EST
Pharmaceutical company Assertio Inc. has been hit with a proposed class action alleging it misled investors by concealing how reliant it was on an unpatented arthritis medicine, and by overstating the...
To view the full article, register now.